Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical implications of aldosterone blockade.

Michael A Weber1

  • 1SUNY Health Science Center at Brooklyn, Brooklyn, NY 11203, USA. michaelwebermd@cs.com

American Heart Journal
|November 8, 2002
PubMed
Summary

Eplerenone, a selective aldosterone blocker, effectively lowers blood pressure in diverse hypertensive patients. It offers additional benefits when standard treatments are insufficient, with minimal side effects like breast tenderness.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Three-Year Durability of Radiofrequency Renal Denervation: SPYRAL HTN-ON MED.

Journal of the American Heart Association·2026
Same author

Effects of aprocitentan on prognostically relevant ambulatory blood pressure-derived variables in resistant hypertension.

Journal of hypertension·2025
Same author

Overcoming Barriers to Developing and Implementing Novel Therapies for Hypertension.

Hypertension (Dallas, Tex. : 1979)·2025
Same author

On-treatment systolic blood pressure and preserved kidney function in hypertensive patients with proteinuria. The VALUE Trial.

Blood pressure·2025
Same author

Renal denervation for managing hypertension: Key elements in selecting and referring patients.

Cardiovascular revascularization medicine : including molecular interventions·2025
Same author

Low Achieved Systolic Blood Pressure Related to Kidney Protection in Diabetic and Non-Diabetic High-Risk Hypertensive Patients.

American journal of hypertension·2025

Area of Science:

  • Cardiovascular medicine
  • Pharmacology

Background:

  • Aldosterone plays a key role in hypertension and cardiac remodeling.
  • Aldosterone blockade is gaining interest for heart failure treatment.

Purpose of the Study:

  • To review clinical studies of eplerenone, a selective aldosterone blocker, in hypertensive patients.

Main Methods:

  • Review of recent clinical studies on eplerenone in hypertension.
  • Analysis of blood pressure and potassium levels in study participants.

Main Results:

  • Eplerenone lowered systolic and diastolic blood pressure in black patients with hypertension, comparable to whites.
  • Eplerenone added to existing therapies significantly reduced blood pressure in inadequately controlled patients.
  • No significant potassium changes were observed; gynecomastia was rare.

Conclusions:

  • Eplerenone is an effective selective aldosterone blocker for hypertension in various populations.
  • It provides additional antihypertensive efficacy when combined with ACE inhibitors or ARBs.
  • Eplerenone demonstrates a favorable safety profile with minimal side effects.

Related Experiment Videos